EDUCATION AND TRAINING
M.D., University of California School of Medicine, Davis, 1989
Internship and Residency in Internal Medicine, University of Washington,
1989-1992
Chief Resident, VA Medical Center, Seattle, Washington, 1992-1993
Endocrinology Fellow, University of Washington,
1993-1995
|
|
Bradley D. Anawalt, M.D.
Associate Professor of Medicine
Staff Physician, General Internal Medicine and
Endocrinology, VA Puget
Sound Health Care System
Assistant Care
Line Manager, Primary and Specialty
Care of VA Puget Sound
Division of General Internal Medicine
OFFICE ADDRESS
VA Puget Sound Health Care System
1660 South Columbian Way
Campus Box 358280 (111M)
Seattle, WA 98108
Email: Bradley.Anawalt@med.va.gov
Academic Office: (206) 764-2345
Fax: (206) 764-2903
HONORS
Paul Beeson Award for excellence in teaching, 1999
Endocrine Society Travel Award, 1999
Endocrine Society Travel Award, 1997
Merck Award for outstanding scholarship, 1989
Alpha Omega Alpha, 1988
CURRENT RESEARCH INTERESTS
Male contraception
Male reproduction
Male hypogonadism
Male reproductive physiology
Effects of androgens on bone, muscle and cognition
REPRESENTATIVE PUBLICATIONS
Herbst
KL, Anawalt BD, Amory JK, Matsumoto AM, Bremner WJ.
The male contraceptive regimen of testosterone and
levonorgestrel significantly increases lean mass in healthy young men
in 4 weeks, but attenuates a decrease in fat mass induced by
testosterone alone.J Clin Endocrinol Metab. 88(3):1167-73, 2003. Grant
NN and Anawalt BD. Androgens
in primary care. Primary
Care Clinics of North America, 30:743-764, 2003. McLachlan
RI, Robertson DM, Pruysers E, Ugoni A, Matsumoto AM, Anawalt BD,
Bremner WJ, Meriggiola CM. Relationship
between serum gonadotropins and spermatogenic suppression in men
undergoing steroidal contraceptive treatment.
J Clin Endocrinol Metab, 89:142-149, 2004. Amory JK, Watts NB, Easley KA, Sutton
PR, Anawalt, BD, Matsumoto AM, Bremner WJ, Tenover L.
Testosterone with Finasteride for Bone Mineral Density and
Prostate Health in Older Men. J Clin Endocrinol Metab,
2004;89:503-510.
Herbst KL, Coviello AD, Page S, Amory JK, Anawalt
BD, Bremner WJ. A
single dose of the potent gonadotropin releasing-hormone antagonist
acyline suppresses gonadotropins and testosterone for 2 weeks in
healthy young men. J Clin
Endocrinol Metab, in press.
|
